cannabidiol + tetrahydrocannabinol
Pre-clinical- Indications
- Multiple myeloma
Company intelligence / Profile preview
One World Cannabis—now operating primarily under the name "One World Products"—produces high-purity CBD and THC derivatives up to 99.9% purity for pharmaceutical and wellness applications. The company operates a fully integrated facility in Colombia's Free Trade Zone with global distribution capabilities. It is recognized for its ESG standards and has been selected by major partners like Stellantis to develop hemp-based bioplastic solutions. Clinical development details are limited; most activity appears commercial/industrial rather than late-stage clinical trials.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on One World Cannabis.